Related Experiment Video

Updated: Jun 13, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

miR-10b targets Tiam1: implications for Rac activation and carcinoma migration

Charlotte H Moriarty1, Bryan Pursell, Arthur M Mercurio

  • 1Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

The Journal of Biological Chemistry
|May 7, 2010
PubMed

Insights

MicroRNA 10b (miR-10b) suppresses breast cancer cell migration and invasion by inhibiting Tiam1 expression. This microRNA targets Tiam1, a key regulator of cell motility and Rac activation, offering a new therapeutic target.

Area of Science:

  • Cancer Cell Biology
  • Molecular Biology
  • MicroRNA Research

Background:

  • MicroRNAs (miRNAs) play crucial roles in cancer progression, including cell migration and invasion.
  • Dysregulation of miR-10b is observed in various cancers, particularly breast cancer.
  • Understanding miRNA-mediated regulation of cellular processes is vital for cancer therapy.

Purpose of the Study:

  • To elucidate the role of miR-10b in regulating breast carcinoma cell migration and invasion.
  • To identify and validate Tiam1 as a direct target of miR-10b.
  • To investigate the impact of miR-10b on Tiam1-mediated Rac activation.

Main Methods:

  • Bioinformatic analysis to predict miR-10b targets.
  • Experimental validation using miR-10b synthetic precursor, expression vector, and antisense oligonucleotide.
  • Assessment of cell migration and invasion assays.
  • Analysis of Tiam1 expression and its interaction with the 3'-UTR of Tiam1.
  • Evaluation of Rac activation.

Main Results:

  • miR-10b directly represses Tiam1 expression in breast carcinoma cells by interacting with its 3'-UTR.
  • miR-10b significantly suppresses breast carcinoma cell migration and invasion.
  • miR-10b inhibits Tiam1-mediated Rac activation, a key pathway in cell motility.

Conclusions:

  • miR-10b acts as a tumor suppressor in breast cancer by inhibiting cell migration and invasion through Tiam1 repression.
  • The findings provide a novel mechanism for miR-10b in regulating Rac activation in breast cancer.
  • This study highlights miR-10b as a potential therapeutic target for breast cancer treatment.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...